Detalhe da pesquisa
1.
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.
Blood;
141(6): 634-644, 2023 02 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36219880
2.
A risk-reward examination of sample multiplexing reagents for single cell RNA-Seq.
Genomics;
116(2): 110793, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38220132
3.
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.
Blood;
137(20): 2721-2735, 2021 05 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33824975
4.
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy.
J Clin Oncol;
38(30): 3506-3517, 2020 10 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32687450
5.
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia.
Leukemia;
33(4): 905-917, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30214012
6.
A novel method for detecting antigen-specific human regulatory T cells.
J Immunol Methods;
377(1-2): 56-61, 2012 Mar 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22265970
7.
A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma.
PLoS One;
7(10): e48424, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23110239
8.
The influence of the zebrafish genetic background on Parkinson's disease-related aspects.
Zebrafish;
8(3): 103-8, 2011 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21745139